Literature DB >> 12225900

Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.

C W Ang1, A P Tio-Gillen, J Groen, P Herbrink, B C Jacobs, R Van Koningsveld, A D M E Osterhaus, F G A Van der Meché, P A van Doorn.   

Abstract

Anti-galactocerebroside (GalC) antibodies are reported to be present in GBS patients with preceding Mycoplasma pneumoniae (MP) infection. We investigated the presence of anti-GalC reactivity in serum of a large group of GBS patients using ELISA and compared this with healthy controls and individuals with an uncomplicated MP infection. Anti-GalC antibody reactivity was present in 12% of the GBS patients. Furthermore, anti-GalC antibodies were associated with MP infections, a relatively mild form of the disease and demyelinating features. Anti-GalC antibodies cross-reacted with MP antigen. In conclusion, anti-GalC antibodies in GBS patients may be induced by molecular mimicry with MP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12225900     DOI: 10.1016/s0165-5728(02)00209-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  16 in total

1.  O-linked protein glycosylation in Mycoplasma.

Authors:  David S Jordan; James M Daubenspeck; Audra H Laube; Matthew B Renfrow; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2013-10-18       Impact factor: 3.501

2.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

3.  Rhamnose biosynthesis in mycoplasmas requires precursor glycans larger than monosaccharide.

Authors:  David S Jordan; James M Daubenspeck; Kevin Dybvig
Journal:  Mol Microbiol       Date:  2013-07-19       Impact factor: 3.501

4.  Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.

Authors:  Michiaki Koga; Masaki Takahashi; Keiko Yokoyama; Takashi Kanda
Journal:  J Neurol       Date:  2015-06-09       Impact factor: 4.849

5.  Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies.

Authors:  Motoi Kuwahara; Makoto Samukawa; Tae Ikeda; Miyuki Morikawa; Rino Ueno; Yukihiro Hamada; Susumu Kusunoki
Journal:  J Neurol       Date:  2016-12-26       Impact factor: 4.849

Review 6.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 7.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

Review 8.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

9.  Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England.

Authors:  Clarence C Tam; Sarah J O'Brien; Laura C Rodrigues
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

10.  Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database.

Authors:  Clarence C Tam; Sarah J O'Brien; Irene Petersen; Amir Islam; Andrew Hayward; Laura C Rodrigues
Journal:  PLoS One       Date:  2007-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.